These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 30956977)

  • 61. ABCB1 and cytochrome P450 polymorphisms: clinical pharmacogenetics of clozapine.
    Jaquenoud Sirot E; Knezevic B; Morena GP; Harenberg S; Oneda B; Crettol S; Ansermot N; Baumann P; Eap CB
    J Clin Psychopharmacol; 2009 Aug; 29(4):319-26. PubMed ID: 19593168
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Plasma clozapine and norclozapine in relation to prescribed dose and other factors in patients aged <18 years: data from a therapeutic drug monitoring service, 1994-2010.
    Couchman L; Bowskill SV; Handley S; Patel MX; Flanagan RJ
    Early Interv Psychiatry; 2013 May; 7(2):122-30. PubMed ID: 22747759
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Fluvoxamine reduces the clozapine dosage needed in refractory schizophrenic patients.
    Lu ML; Lane HY; Chen KP; Jann MW; Su MH; Chang WH
    J Clin Psychiatry; 2000 Aug; 61(8):594-9. PubMed ID: 10982203
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pharmacokinetic changes of clozapine and norclozapine in a rat model of non-alcoholic fatty liver disease induced by orotic acid.
    Li Z; Lee SH; Jeong HJ; Kang HE
    Xenobiotica; 2021 Mar; 51(3):324-334. PubMed ID: 33185134
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A target-dose finding study of clozapine in patients with schizophrenia.
    Bennett JA; Keck PE
    Ann Clin Psychiatry; 1996 Mar; 8(1):19-21. PubMed ID: 8743644
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Association of clozapine-related metabolic disturbances with CYP3A4 expression in patients with schizophrenia.
    Menus Á; Kiss Á; Tóth K; Sirok D; Déri M; Fekete F; Csukly G; Monostory K
    Sci Rep; 2020 Dec; 10(1):21283. PubMed ID: 33277605
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Neuroleptic-resistant schizophrenic patients treated by clozapine: clinical evolution, plasma and red blood cell clozapine and desmethylclozapine levels.
    Aymard N; Baldacci C; Leyris A; Smagghe PO; Tribolet S; Vacheron MN; Viala A; Caroli F
    Therapie; 1997; 52(3):227-32. PubMed ID: 9366107
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of hypertriglyceridemia on the pharmacokinetics and blood-brain barrier penetration of clozapine and norclozapine following administration to rats.
    Gershkovich P; Sivak O; Sharma A; Barr AM; Procyshyn R; Wasan KM
    Eur Neuropsychopharmacol; 2010 Aug; 20(8):545-52. PubMed ID: 20163937
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The clozapine to norclozapine ratio: a narrative review of the clinical utility to minimize metabolic risk and enhance clozapine efficacy.
    Costa-Dookhan KA; Agarwal SM; Chintoh A; Tran VN; Stogios N; Ebdrup BH; Sockalingam S; Rajji TK; Remington GJ; Siskind D; Hahn MK
    Expert Opin Drug Saf; 2020 Jan; 19(1):43-57. PubMed ID: 31770500
    [No Abstract]   [Full Text] [Related]  

  • 70. Effect of Coffee and Chocolate Ingestion on Clozapine Dose and on Plasma Clozapine and Norclozapine Concentrations in Clinical Practice.
    Flanagan RJ; Obee SJ; Kim AHM; Every-Palmer S
    J Clin Psychopharmacol; 2024 Mar-Apr 01; 44(2):161-167. PubMed ID: 38421925
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A population pharmacokinetic model to guide clozapine dose selection, based on age, sex, ethnicity, body weight and smoking status.
    Reeves S; Bertrand J; Obee SJ; Hunter S; Howard R; Flanagan RJ
    Br J Clin Pharmacol; 2024 Jan; 90(1):135-145. PubMed ID: 36793249
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Quantification of the steady-state plasma concentrations of clozapine and N-desmethylclozapine in Japanese patients with schizophrenia using a novel HPLC method and the effects of CYPs and ABC transporters polymorphisms.
    Akamine Y; Sugawara-Kikuchi Y; Uno T; Shimizu T; Miura M
    Ann Clin Biochem; 2017 Nov; 54(6):677-685. PubMed ID: 27932669
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A systematic review and meta-analysis of the association between clozapine and norclozapine serum levels and peripheral adverse drug reactions.
    Tan MSA; Honarparvar F; Falconer JR; Parekh HS; Pandey P; Siskind DJ
    Psychopharmacology (Berl); 2021 Mar; 238(3):615-637. PubMed ID: 33410989
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Clozapine: Dose, Sex, Ethnicity, Smoking Habit, Age, Body Weight, and Plasma Clozapine and N -Desmethylclozapine (Norclozapine) Concentrations in Clinical Practice.
    Flanagan RJ; Hunter S; Obee SJ; Reeves S
    J Clin Psychopharmacol; 2023 Mar-Apr 01; 43(2):131-138. PubMed ID: 36735578
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Evidence from a population pharmacokinetics analysis for a major effect of CYP1A2 activity on inter- and intraindividual variations of clozapine clearance.
    Dailly E; Urien S; Chanut E; Claudel B; Guerra N; Femandez C; Jolliet P; Bourin M
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 May; 26(4):699-703. PubMed ID: 12188102
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Reversible metabolism of clozapine and clozapine N-oxide in schizophrenic patients.
    Chang WH; Lin SK; Lane HY; Wei FC; Hu WH; Lam YW; Jann MW
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 Jul; 22(5):723-39. PubMed ID: 9723115
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clozapine ultrarapid metabolism during weak induction probably exists but requires careful diagnosis. A literature review, five new cases and a proposed definition.
    Schoretsanitis G; Anıl Yağcıoğlu AE; Ruan CJ; Eap CB; Molden E; Baptista T; Clark SR; Fernandez-Egea E; Kim SH; Lane HY; Leung J; Maroñas Amigo O; Motuca M; Olmos I; Every-Palmer S; Procyshyn RM; Rohde C; Satish S; Schulte PFJ; Spina E; Takeuchi H; Verdoux H; Correll CU; de Leon J
    Schizophr Res; 2024 Jun; 268():302-307. PubMed ID: 37268453
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clinical and genetic influencing factors on clozapine pharmacokinetics in Tunisian schizophrenic patients.
    Ammar H; Chadli Z; Mhalla A; Khouadja S; Hannachi I; Alshaikheid M; Slama A; Ben Fredj N; Ben Fadhel N; Ben Romdhane H; Chaabane A; Boughattas NA; Gaha L; Zarrouk L; Aouam K
    Pharmacogenomics J; 2021 Oct; 21(5):551-558. PubMed ID: 33731885
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effect of post-mortem changes on peripheral and central whole blood and tissue clozapine and norclozapine concentrations in the domestic pig (Sus scrofa).
    Flanagan RJ; Amin A; Seinen W
    Forensic Sci Int; 2003 Mar; 132(1):9-17. PubMed ID: 12689746
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Serum concentrations of clozapine and norclozapine in the prediction of relapse of patients with schizophrenia.
    Xiang YQ; Zhang ZJ; Weng YZ; Zhai YM; Li WB; Cai ZJ; Tan QR; Wang CY
    Schizophr Res; 2006 Apr; 83(2-3):201-10. PubMed ID: 16524698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.